Chemours Total Other Income Expense Net vs Operating Income Analysis
CC Stock | USD 21.82 0.10 0.46% |
Chemours financial indicator trend analysis is way more than just evaluating Chemours prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Chemours is a good investment. Please check the relationship between Chemours Total Other Income Expense Net and its Operating Income accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
Total Other Income Expense Net vs Operating Income
Total Other Income Expense Net vs Operating Income Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Chemours Total Other Income Expense Net account and Operating Income. At this time, the significance of the direction appears to have strong relationship.
The correlation between Chemours' Total Other Income Expense Net and Operating Income is 0.73. Overlapping area represents the amount of variation of Total Other Income Expense Net that can explain the historical movement of Operating Income in the same time period over historical financial statements of Chemours Co, assuming nothing else is changed. The correlation between historical values of Chemours' Total Other Income Expense Net and Operating Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Other Income Expense Net of Chemours Co are associated (or correlated) with its Operating Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Income has no effect on the direction of Total Other Income Expense Net i.e., Chemours' Total Other Income Expense Net and Operating Income go up and down completely randomly.
Correlation Coefficient | 0.73 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Total Other Income Expense Net
Operating Income
Operating Income is the amount of profit realized from Chemours operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Chemours Co is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Most indicators from Chemours' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Chemours current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. At present, Chemours' Enterprise Value Multiple is projected to increase significantly based on the last few years of reporting.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 1.4B | 1.6B | 1.3B | 1.2B | Total Revenue | 6.3B | 6.8B | 6.0B | 5.1B |
Chemours fundamental ratios Correlations
Click cells to compare fundamentals
Chemours Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Chemours fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 164.8M | 166.3M | 168.7M | 158.3M | 148.9M | 140.1M | |
Total Assets | 7.3B | 7.1B | 7.6B | 7.6B | 8.3B | 7.5B | |
Other Current Liab | 477M | 449M | 545M | 475M | 1.2B | 1.3B | |
Total Current Liabilities | 1.5B | 1.4B | 1.9B | 1.9B | 2.5B | 1.8B | |
Total Stockholder Equity | 689M | 813M | 1.1B | 1.1B | 737M | 1.1B | |
Other Liab | 751M | 626M | 707M | 854M | 982.1M | 711.9M | |
Property Plant And Equipment Net | 3.9B | 3.7B | 3.4B | 3.4B | 3.5B | 3.6B | |
Accounts Payable | 923M | 820M | 1.2B | 1.2B | 1.1B | 1.1B | |
Non Current Assets Total | 4.5B | 4.4B | 4.2B | 4.4B | 4.4B | 4.4B | |
Non Currrent Assets Other | 391M | 252M | 310M | 573M | 374M | 416.1M | |
Other Assets | 292M | 405M | 547M | 725M | 833.8M | 424.1M | |
Long Term Debt | 4.0B | 4.0B | 3.7B | 3.6B | 4.0B | 3.2B | |
Net Receivables | 674M | 511M | 720M | 626M | 610M | 602.4M | |
Liabilities And Stockholders Equity | 7.3B | 7.1B | 7.6B | 7.6B | 8.3B | 7.5B | |
Non Current Liabilities Total | 5.0B | 4.8B | 4.6B | 4.6B | 5.0B | 4.1B | |
Inventory | 1.1B | 939M | 1.1B | 1.4B | 1.4B | 1.2B | |
Other Current Assets | 81M | 156M | 150M | 82M | 670M | 703.5M | |
Other Stockholder Equity | (213M) | (182M) | (303M) | (722M) | (773M) | (734.4M) | |
Total Liab | 6.6B | 6.3B | 6.5B | 6.5B | 7.5B | 6.0B | |
Property Plant And Equipment Gross | 3.9B | 3.7B | 9.2B | 9.4B | 9.6B | 5.2B | |
Total Current Assets | 2.8B | 2.6B | 3.3B | 3.2B | 3.8B | 3.0B | |
Accumulated Other Comprehensive Income | (349M) | (310M) | (364M) | (343M) | (274M) | (287.7M) | |
Short Term Debt | 134M | 78M | 84M | 141M | 106M | 97.8M | |
Intangible Assets | 28M | 21M | 14M | 6M | 3M | 2.9M | |
Property Plant Equipment | 3.9B | 3.5B | 3.4B | 3.2B | 3.6B | 3.5B | |
Net Tangible Assets | 515M | 646M | 973M | 992M | 892.8M | 710.5M | |
Retained Earnings | 1.2B | 1.3B | 1.7B | 2.2B | 1.8B | 1.1B | |
Cash | 943M | 1.1B | 1.5B | 1.1B | 1.2B | 1.1B | |
Deferred Long Term Liab | 148M | 36M | 49M | 61M | 54.9M | 96.1M | |
Long Term Investments | 162M | 167M | 169M | 175M | 158M | 171.6M | |
Short Long Term Debt | 13M | 134M | 21M | 25M | 51M | 41.5M | |
Short Long Term Debt Total | 4.4B | 4.3B | 3.9B | 3.8B | 4.3B | 4.4B | |
Net Debt | 3.5B | 3.2B | 2.5B | 2.7B | 3.1B | 2.4B | |
Cash And Short Term Investments | 943M | 1.1B | 1.5B | 1.1B | 1.2B | 1.2B | |
Retained Earnings Total Equity | 1.2B | 1.3B | 1.7B | 2.2B | 2.5B | 2.6B | |
Long Term Debt Total | 4.0B | 4.0B | 3.7B | 3.6B | 3.2B | 3.1B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Diversified Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.65) | Dividend Share 1 | Earnings Share 0.5 | Revenue Per Share 38.519 | Quarterly Revenue Growth 0.009 |
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.